Acridinyl Anisidide Other names: Amsacrine
Chemical formula: C₂₁H₁₉N₃O₃S Molecular mass: 393.459 g/mol PubChem compound: 2179
Active ingredient description
Amsidine is a sterile antitumour chemotherapeutic agent for intravenous infusion. Although not completely clarified, the mode of action of amsacrine is related to its property of binding the DNA through intercalation and external (electrostatic) forces.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC Group | Classification | |
|---|---|---|
| L01XX01 | Amsacrine | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents |
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Document | Type | Information Source | |
|---|---|---|---|
| AMSIDINE 50mg/ml Concentrate and solvent for solution for infusion | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |
Medicines
Acridinyl Anisidide is an active ingredient of these brands:
Austria (AT)Estonia (EE)Finland (FI)France (FR)Ireland (IE)Netherlands (NL)Poland (PL)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.